all 208047 studies found for:    ALL
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Diagnosis of Hallux Valgus by Using a Foot Pressure Platform as an Alternative to Radiological Images
Condition: Hallux Valgus
Intervention: Device: foot pressure plate form
2 Not yet recruiting Consolidating Tools for Outcomes in Resuscitation
Conditions: Cardiac Arrest;   Cardiopulmonary Resuscitation;   Simulation;   Education
Interventions: Device: Knowledge-based cognitive aid;   Device: Cognitive aids with roles defined (CARD);   Device: Integrated cognitive aids
3 Recruiting Brad Arrhythmia Induced by Repeated Succinylcholine During Gynecological Laparoscopic Surgery
Condition: Bradycardia
Interventions: Drug: IM atropine;   Drug: IV atropine;   Drug: Atropine mixed with second dose succinylcholine;   Drug: IM normal saline;   Drug: IV normal saline;   Drug: Normal saline mixed with second dose succinylcholine
4 Recruiting An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Condition: Hyperphosphatemia
Interventions: Drug: Tenapanor;   Drug: Placebo
5 Not yet recruiting Early Intensive Physical Therapy in Subarachnoid Hemorrhage
Condition: Subarachnoid Hemorrhage
Intervention: Other: Physical Therapy
6 Recruiting Which Parameters of Short-term Blood Pressure Variability Best Predict Early Outcomes in Acute Ischemic Stroke
Condition: Stroke
Intervention:
7 Not yet recruiting Myeloablative Conditioning and Haplo AlloSCT for Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Defibrotide
8 Not yet recruiting Study of CGX1321 in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors;   Colorectal Adenocarcinoma;   Gastric Adenocarcinoma;   Pancreatic Adenocarcinoma;   Bile Duct Carcinoma;   Hepatocellular Carcinoma;   Esophageal Carcinoma
Intervention: Drug: CGX1321
9 Not yet recruiting Satisfaction Rates Among Parents of Children With Autism in the ED
Condition: Autism Spectrum Disorder
Intervention: Behavioral: Questionnaire
10 Recruiting A Study of HCC High Risk Group Using Two Surveillance Tools
Condition: HCC
Intervention: Drug: non-ionic monomer iodinated CT contrast media
11 Recruiting Evaluation of N1539 Following Bunionectomy Surgery
Condition: Pain, Post-operative
Interventions: Drug: N1539;   Drug: Intravenous Placebo
12 Active, not recruiting Radiofrequency Ablation Using Cooled-Wet Electrode
Condition: HCC
Interventions: Device: cooled-wet electrode;   Device: separable clustered electrode
13 Active, not recruiting Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®)
Conditions: HCC;   Metastasis
Interventions: Device: DSM;   Device: separable clustered electrode
14 Recruiting Effects of Vasopressors on Immune Response
Condition: Endotoxemia
Interventions: Drug: Norepinephrine;   Drug: Phenylephrine;   Drug: Vasopressins;   Drug: Placebo
15 Recruiting GrafixPRIME®: Randomized, Single-Blind Study for the Treatment of Chronic Diabetic Foot Ulcers
Condition: Foot Ulcer, Diabetic
Interventions: Other: GrafixPRIME®;   Procedure: Dressing Application;   Device: Off-loading (walking boot)
16 Not yet recruiting Investigation of Cannabis for Pain and Inflammation in Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Smoked Cannabis High CBD/low THC;   Drug: Smoked Placebo Cannabis Low CBD/low THC
17 Not yet recruiting Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Conditions: Solid Tumor Cancers;   Lung Cancer;   Bladder Cancer;   Urinary Tract Cancers
Intervention: Drug: ado-trastuzumab emtansine
18 Recruiting Inspire® Upper Airway Stimulation System
Condition: Obstructive Sleep Apnea
Intervention: Device: Inspire® Upper Airway Stimulation (UAS) System
19 Recruiting Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Interventions: Biological: VAY736;   Biological: VAY736 placebo
20 Not yet recruiting Low Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Stroke
Interventions: Drug: Moderate Dose Hydroxyurea;   Drug: Low Dose Hydroxyurea

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years